Objective: The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies.
Nippon India Pharma Fund - Growth is an Equity - Sector - Healthcare fund. The fund was launched inJun 05, 2004. Its risk level is . The NAV of the fund as onAug 04, 2025 is ₹517.47. Its expense ratio is 1.91 %. The fund has an AUM of ₹8,569.15 Cr.The fund is managed bySailesh Raj Bhan,Kinjal Desai,Akshay Sharma.
The minimum initial investment is ₹5000 in Lumpsum mode.